CNJ-016 Injection and Insulin aspart, recombinant Subcutaneous
Determining the interaction of CNJ-016 Injection and Insulin aspart, recombinant Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: vaccinia immune globulin
Brand name: Baciguent, Probiotic Formula, Proferrin-ES
Synonyms: n.a.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- CNJ-016 Injection-Insulin degludec
- CNJ-016 Injection-Insulin Degludec (U-100) Prefilled Pens
- CNJ-016 Injection-Insulin Degludec (U-100) Vials
- CNJ-016 Injection-Insulin Degludec (U-200) Prefilled Pens
- CNJ-016 Injection-Insulin degludec and liraglutide
- CNJ-016 Injection-Insulin degludec and liraglutide Subcutaneous
- Insulin aspart, recombinant Subcutaneous-Co-Gesic
- Insulin aspart, recombinant Subcutaneous-Co-trimoxazole
- Insulin aspart, recombinant Subcutaneous-Co-Veratrol
- Insulin aspart, recombinant Subcutaneous-Coagadex
- Insulin aspart, recombinant Subcutaneous-Coagulation factor IX
- Insulin aspart, recombinant Subcutaneous-Coagulation factor ix recombinant Intravenous